AllianceBernstein’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Buy |
5,279,565
+4,605,949
| +684% | +$888M | 0.33% | 60 |
|
|
2025
Q4 | $124M | Sell |
673,616
-26,561
| -4% | -$4.66M | 0.04% | 326 |
|
|
2025
Q3 | $107M | Sell |
700,177
-342,136
| -33% | -$51.8M | 0.03% | 374 |
|
|
2025
Q2 | $146M | Sell |
1,042,313
-51,028
| -5% | -$7.15M | 0.05% | 269 |
|
|
2025
Q1 | $161M | Sell |
1,093,341
-457,172
| -29% | -$66.1M | 0.06% | 251 |
|
|
2024
Q4 | $203M | Buy |
1,550,513
+611,335
| +65% | +$85.6M | 0.07% | 213 |
|
|
2024
Q3 | $146M | Sell |
939,178
-10,832
| -1% | -$1.75M | 0.05% | 290 |
|
|
2024
Q2 | $148M | Sell |
950,010
-137,432
| -13% | -$20.7M | 0.05% | 271 |
|
|
2024
Q1 | $147M | Buy |
1,087,442
+347,337
| +47% | +$46M | 0.05% | 298 |
|
|
2023
Q4 | $99.7M | Sell |
740,105
-27,720
| -4% | -$3.6M | 0.04% | 407 |
|
|
2023
Q3 | $104M | Buy |
767,825
+667,456
| +665% | +$91.2M | 0.04% | 365 |
|
|
2023
Q2 | $14.4M | Buy |
100,369
+35,707
| +55% | +$5.25M | 0.01% | 974 |
|
|
2023
Q1 | $8.98M | Sell |
64,662
-31,157
| -33% | -$4.19M | ﹤0.01% | 1146 |
|
|
2022
Q4 | $13M | Sell |
95,819
-55,462
| -37% | -$6.96M | 0.01% | 970 |
|
|
2022
Q3 | $16.6M | Sell |
151,281
-72,937
| -33% | -$9.25M | 0.01% | 892 |
|
|
2022
Q2 | $29.6M | Sell |
224,218
-672,473
| -75% | -$88.2M | 0.01% | 726 |
|
|
2022
Q1 | $119M | Sell |
896,691
-681,842
| -43% | -$81.8M | 0.05% | 353 |
|
|
2021
Q4 | $184M | Buy |
1,578,533
+36,113
| +2% | +$4.25M | 0.07% | 268 |
|
|
2021
Q3 | $185M | Sell |
1,542,420
-546,917
| -26% | -$63.7M | 0.07% | 244 |
|
|
2021
Q2 | $250M | Buy |
2,089,337
+1,946,900
| +1,367% | +$214M | 0.1% | 196 |
|
|
2021
Q1 | $14.2M | Buy |
142,437
+135,007
| +1,817% | +$13.6M | 0.01% | 1048 |
|
|
2020
Q4 | $743K | Sell |
7,430
-4,104
| -36% | -$435K | ﹤0.01% | 2416 |
|
|
2020
Q3 | $1.26M | Sell |
11,534
-42,614
| -79% | -$4.74M | ﹤0.01% | 2077 |
|
|
2020
Q2 | $5.73M | Buy |
54,148
+14,326
| +36% | +$1.48M | ﹤0.01% | 1255 |
|
|
2020
Q1 | $3.56M | Buy |
39,822
+9,891
| +33% | +$931K | ﹤0.01% | 1341 |
|
|
2019
Q4 | $2.98M | Buy |
29,931
+4,981
| +20% | +$469K | ﹤0.01% | 1732 |
|
|
2019
Q3 | $2.22M | Sell |
24,950
-31,849
| -56% | -$2.76M | ﹤0.01% | 1866 |
|
|
2019
Q2 | $4.69M | Buy |
56,799
+16,386
| +41% | +$1.28M | ﹤0.01% | 1452 |
|
|
2019
Q1 | $3.27M | Sell |
40,413
-3,192
| -7% | -$252K | ﹤0.01% | 1622 |
|
|
2018
Q4 | $3.31M | Sell |
43,605
-564,999
| -93% | -$44.1M | ﹤0.01% | 1527 |
|
|
2018
Q3 | $48.2M | Sell |
608,604
-107,338
| -15% | -$8.12M | 0.03% | 534 |
|
|
2018
Q2 | $50.3M | Buy |
715,942
+678,406
| +1,807% | +$48.8M | 0.04% | 504 |
|
|
2018
Q1 | $2.63M | Buy |
+37,536
| New | +$2.6M | ﹤0.01% | 1644 |
|
|
2015
Q2 | – | Sell |
-2,038
| Closed | -$139K | – | 3016 |
|
|
2015
Q1 | $139K | Sell |
2,038
-50
| -2% | -$3.47K | ﹤0.01% | 2948 |
|
|
2014
Q4 | $147K | Sell |
2,088
-90
| -4% | -$6.44K | ﹤0.01% | 2896 |
|
|
2014
Q3 | $156K | Sell |
2,178
-8,093
| -79% | -$592K | ﹤0.01% | 2848 |
|
|
2014
Q2 | $763K | Sell |
10,271
-1,140
| -10% | -$82.4K | ﹤0.01% | 2381 |
|
|
2014
Q1 | $740K | Buy |
11,411
+5,378
| +89% | +$347K | ﹤0.01% | 2304 |
|
|
2013
Q4 | $358K | Sell |
6,033
-6,955
| -54% | -$378K | ﹤0.01% | 2592 |
|
|
2013
Q3 | $674K | Sell |
12,988
-49,868
| -79% | -$2.5M | ﹤0.01% | 2319 |
|
|
2013
Q2 | $2.97M | Buy |
+62,856
| New | +$3.2M | ﹤0.01% | 1338 |
|
Other funds holding AZN
IA
VCM
VAM
AllianceBernstein's AZN Position: Q1 2026 in Review
AllianceBernstein increased its AstraZeneca (AZN) stake by 684% in Q1 2026, buying an estimated $888M and bringing the position to 5,279,565 shares worth $1.02B. The position accounts for 0.33% of the portfolio, ranked #60.
AllianceBernstein first reported a position in AZN in Q2 2013 and has held it in 41 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- AllianceBernstein held 5,279,565 shares of AstraZeneca worth $1.02B as of Q1 2026.
- AllianceBernstein bought 4,605,949 AstraZeneca shares in Q1 2026, an estimated $888M.
- AstraZeneca made up 0.33% of AllianceBernstein's portfolio in Q1 2026, its #60 holding.
- AllianceBernstein first reported a position in AstraZeneca in Q2 2013 and has held it in 41 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.